LT4778B - Dezinfekavimo kompozicija - Google Patents
Dezinfekavimo kompozicija Download PDFInfo
- Publication number
- LT4778B LT4778B LT2000087A LT2000087A LT4778B LT 4778 B LT4778 B LT 4778B LT 2000087 A LT2000087 A LT 2000087A LT 2000087 A LT2000087 A LT 2000087A LT 4778 B LT4778 B LT 4778B
- Authority
- LT
- Lithuania
- Prior art keywords
- composition
- weight
- alcohol
- disinfectant
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 230000000249 desinfective effect Effects 0.000 title abstract description 7
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims abstract description 20
- 229940068939 glyceryl monolaurate Drugs 0.000 claims abstract description 17
- 239000000645 desinfectant Substances 0.000 claims description 39
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims description 19
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000416 hydrocolloid Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 description 13
- 239000008267 milk Substances 0.000 description 13
- 210000004080 milk Anatomy 0.000 description 13
- 210000002445 nipple Anatomy 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000003641 microbiacidal effect Effects 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 210000000481 breast Anatomy 0.000 description 10
- 244000005700 microbiome Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000004599 antimicrobial Substances 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000194031 Enterococcus faecium Species 0.000 description 4
- 241000588770 Proteus mirabilis Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- -1 propylene glycol monosaccharic acid Chemical compound 0.000 description 3
- 210000001082 somatic cell Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 230000002925 chemical effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- DWKQNRUYIOGYLP-UHFFFAOYSA-N 3-methyl-2-pentylphenol Chemical compound CCCCCC1=C(C)C=CC=C1O DWKQNRUYIOGYLP-UHFFFAOYSA-N 0.000 description 1
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002402 hexoses Chemical group 0.000 description 1
- 230000003165 hydrotropic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 239000002855 microbicide agent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004957 nitroimidazoles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000006208 topical dosage form Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Emergency Medicine (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK38798 | 1998-03-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2000087A LT2000087A (lt) | 2001-01-25 |
| LT4778B true LT4778B (lt) | 2001-04-25 |
Family
ID=8092930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2000087A LT4778B (lt) | 1998-03-19 | 2000-09-14 | Dezinfekavimo kompozicija |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6414023B1 (no) |
| EP (1) | EP1063886B1 (no) |
| AT (1) | ATE233484T1 (no) |
| AU (1) | AU740138B2 (no) |
| CA (1) | CA2321658C (no) |
| DE (1) | DE69905700T2 (no) |
| DK (1) | DK1063886T3 (no) |
| EE (1) | EE04136B1 (no) |
| ES (1) | ES2191417T3 (no) |
| IL (1) | IL137891A (no) |
| LT (1) | LT4778B (no) |
| LV (1) | LV12582B (no) |
| NO (1) | NO323049B1 (no) |
| NZ (1) | NZ506681A (no) |
| PL (1) | PL196077B1 (no) |
| PT (1) | PT1063886E (no) |
| RU (1) | RU2221557C2 (no) |
| WO (1) | WO1999046987A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
| US20070003508A1 (en) | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
| US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
| US8795638B1 (en) | 2003-08-26 | 2014-08-05 | Nevada Naturals Inc. | Compositions for dental care |
| US20100056628A1 (en) * | 2006-09-07 | 2010-03-04 | Stockel Richard F | Preservative compositions |
| US8193244B1 (en) | 2008-05-29 | 2012-06-05 | Nevada Naturals, Inc. | Antimicrobial agents |
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| US20070185202A1 (en) * | 2004-03-03 | 2007-08-09 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
| WO2006099325A2 (en) | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
| BRPI0608690B8 (pt) | 2005-03-10 | 2021-05-25 | 3M Innovative Properties Co | uso de uma composição antimicrobiana |
| BRPI0608691A2 (pt) | 2005-03-10 | 2010-12-07 | 3M Innovative Properties Company | composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição |
| MX2007010904A (es) * | 2005-03-10 | 2007-12-05 | 3M Innovative Properties Co | Panuelo para mascota antimicrobiano. |
| US9023891B2 (en) | 2008-05-29 | 2015-05-05 | Nevada Naturals, Inc. | Synergistic antimicrobial agents |
| US8999302B1 (en) * | 2009-10-22 | 2015-04-07 | Aplicare, Inc. | Skin dye protectant formulations |
| US8834857B1 (en) | 2011-01-18 | 2014-09-16 | Nevada Naturals Inc. | Deodorizing and skin cleaning |
| US10624368B1 (en) | 2018-02-01 | 2020-04-21 | Nevada Naturals Inc. | Control of pathogenic bacteria in foods |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123528A (en) | 1964-03-03 | New therapeutic compositions | ||
| US4067997A (en) | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
| US4485029A (en) | 1984-03-19 | 1984-11-27 | Minnesota Mining And Manufacturing Company | Disinfecting method and compositions |
| US4921694A (en) | 1987-06-24 | 1990-05-01 | Beiersdorf Aktiengesellschaft | Deodorizing and antimicrobial composition for use in cosmetic or topical formulations |
| WO1993020812A1 (en) | 1992-04-14 | 1993-10-28 | Bioglan Ab | Potentiation of antimicrobial effects |
| DE4411664A1 (de) | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen |
| WO1996006153A2 (en) | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
| WO1996018300A2 (en) | 1994-12-14 | 1996-06-20 | Alcide Corporation | Adherent disinfecting compositions and methods relating thereto |
| US5569461A (en) | 1995-02-07 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Topical antimicrobial composition and method |
| WO1998009520A1 (en) | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2049467C1 (ru) * | 1993-04-16 | 1995-12-10 | Научно-исследовательская фирма "Ультрасан" | Антибактериальный, противовоспалительный препарат |
| RU2091070C1 (ru) * | 1995-07-03 | 1997-09-27 | Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии | Препарат "аниксид" для лечения и профилактики мастита крупного рогатого скота |
| RU2093141C1 (ru) * | 1996-11-27 | 1997-10-20 | Виталий Алексеевич Ириков | Средство для ухода за кожей ног |
| ATE206047T1 (de) | 1997-01-09 | 2001-10-15 | Bifodan As | Verwendung von dichlorobenzyl alkohol zur herstellung einer zusammenstellung zur topischen behandlung von entzündungen |
-
1999
- 1999-03-16 AU AU27142/99A patent/AU740138B2/en not_active Ceased
- 1999-03-16 PT PT99907340T patent/PT1063886E/pt unknown
- 1999-03-16 EP EP99907340A patent/EP1063886B1/en not_active Expired - Lifetime
- 1999-03-16 RU RU2000126306/15A patent/RU2221557C2/ru not_active IP Right Cessation
- 1999-03-16 DK DK99907340T patent/DK1063886T3/da active
- 1999-03-16 ES ES99907340T patent/ES2191417T3/es not_active Expired - Lifetime
- 1999-03-16 WO PCT/DK1999/000130 patent/WO1999046987A1/en not_active Ceased
- 1999-03-16 IL IL13789199A patent/IL137891A/xx not_active IP Right Cessation
- 1999-03-16 NZ NZ506681A patent/NZ506681A/xx not_active IP Right Cessation
- 1999-03-16 DE DE69905700T patent/DE69905700T2/de not_active Expired - Lifetime
- 1999-03-16 PL PL343030A patent/PL196077B1/pl unknown
- 1999-03-16 AT AT99907340T patent/ATE233484T1/de active
- 1999-03-16 EE EEP200000550A patent/EE04136B1/xx not_active IP Right Cessation
- 1999-03-16 US US09/646,523 patent/US6414023B1/en not_active Expired - Lifetime
- 1999-03-16 CA CA002321658A patent/CA2321658C/en not_active Expired - Fee Related
-
2000
- 2000-08-22 LV LVP-00-112A patent/LV12582B/en unknown
- 2000-09-14 LT LT2000087A patent/LT4778B/lt not_active IP Right Cessation
- 2000-09-15 NO NO20004609A patent/NO323049B1/no not_active IP Right Cessation
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123528A (en) | 1964-03-03 | New therapeutic compositions | ||
| US4067997A (en) | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
| US4485029A (en) | 1984-03-19 | 1984-11-27 | Minnesota Mining And Manufacturing Company | Disinfecting method and compositions |
| US4921694A (en) | 1987-06-24 | 1990-05-01 | Beiersdorf Aktiengesellschaft | Deodorizing and antimicrobial composition for use in cosmetic or topical formulations |
| WO1993020812A1 (en) | 1992-04-14 | 1993-10-28 | Bioglan Ab | Potentiation of antimicrobial effects |
| DE4411664A1 (de) | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen |
| WO1996006153A2 (en) | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
| WO1996018300A2 (en) | 1994-12-14 | 1996-06-20 | Alcide Corporation | Adherent disinfecting compositions and methods relating thereto |
| US5569461A (en) | 1995-02-07 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Topical antimicrobial composition and method |
| WO1998009520A1 (en) | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| NO323049B1 (no) | 2006-12-27 |
| PT1063886E (pt) | 2003-07-31 |
| CA2321658A1 (en) | 1999-09-23 |
| WO1999046987A1 (en) | 1999-09-23 |
| EE04136B1 (et) | 2003-10-15 |
| IL137891A (en) | 2005-03-20 |
| ATE233484T1 (de) | 2003-03-15 |
| DE69905700T2 (de) | 2003-11-13 |
| EP1063886A1 (en) | 2001-01-03 |
| NO20004609D0 (no) | 2000-09-15 |
| LV12582B (en) | 2001-03-20 |
| PL343030A1 (en) | 2001-07-30 |
| PL196077B1 (pl) | 2007-12-31 |
| CA2321658C (en) | 2008-11-18 |
| AU2714299A (en) | 1999-10-11 |
| LT2000087A (lt) | 2001-01-25 |
| RU2221557C2 (ru) | 2004-01-20 |
| DE69905700D1 (de) | 2003-04-10 |
| NO20004609L (no) | 2000-09-15 |
| EP1063886B1 (en) | 2003-03-05 |
| EE200000550A (et) | 2002-04-15 |
| US6414023B1 (en) | 2002-07-02 |
| IL137891A0 (en) | 2001-10-31 |
| ES2191417T3 (es) | 2003-09-01 |
| NZ506681A (en) | 2002-12-20 |
| DK1063886T3 (da) | 2003-06-23 |
| AU740138B2 (en) | 2001-11-01 |
| LV12582A (en) | 2000-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2221557C2 (ru) | Дезинфицирующий состав | |
| US6488942B1 (en) | Disinfecting agent | |
| US5651977A (en) | Adherent disinfecting compositions and methods relating thereto | |
| Hübner et al. | Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds | |
| US8043626B2 (en) | Fatty acid antimicrobial | |
| KR101534381B1 (ko) | 항균 조성물 | |
| US5569461A (en) | Topical antimicrobial composition and method | |
| US8778369B2 (en) | Barrier film-forming compositions and methods of use | |
| CN1186413A (zh) | 湿性细菌素消毒手巾及其应用 | |
| US20070249712A1 (en) | Peracetic teat dip | |
| US9918991B2 (en) | Topical antimicrobial compositions and methods of using same | |
| EP0744895B1 (en) | Adherent disinfecting compositions and methods relating thereto | |
| US5618841A (en) | Composition of iodophor teat dip for the prevention of mastitis and a process for using the same | |
| US20060177518A1 (en) | Peracetic teat dip | |
| US6107344A (en) | Aqueous germicidal film forming composition for applying to teats of dairy cows | |
| JPH0656675A (ja) | 家畜の乳房炎予防剤 | |
| US12465059B2 (en) | Concentrated formic acid composition and its uses thereof | |
| JP2648886B2 (ja) | 家蓄の乳房炎を予防する方法 | |
| AU2002233873B2 (en) | Prophylactic teat treatment | |
| EP0692253A1 (en) | Prophylatic for domestic animal mastitis | |
| RU2088218C1 (ru) | Состав для обработки гигиенических салфеток | |
| JP3460366B2 (ja) | 口腔用組成物 | |
| CN118252760A (zh) | 一种消毒杀菌湿巾及其制备方法 | |
| CZ37412U1 (cs) | Dezinfekční přípravek | |
| WO2005048709A1 (en) | Use of panthenol in teat dip/spray preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9A | Lapsed patents |
Effective date: 20140316 |